LDN193189 (Tetrahydrochloride) [2310134-98-4]
Référence HY-12071A-5mg
Conditionnement : 5mg
Marque : MedChemExpress
LDN193189 Tetrahydrochloride is a selective BMP type I receptor inhibitor, which efficiently inhibits ALK2 and ALK3 (IC50=5 nM and 30 nM, respectively), with weaker effects on ALK4, ALK5 and ALK7 (IC50≥500 nM).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
LDN193189 Tetrahydrochloride Chemical Structure
CAS No. : 2310134-98-4
* Veuillez sélectionner la quantité avant d'ajouter des articles.
This product is a controlled substance and not for sale in your territory.
- Western blot and grey analysis of CYP11a1, CYP19a1, BCL2, CALR, CHOP, caspase3, caspase12, PERK, and GRP78. qRT-PCR analyzed ATF4, caspase3, and GRP78 mRNAs. The relieving function of BMP4 on ER stress is diminished after blockade of BMP receptor I (BMPRI) with DM-3189.
- H9c2 cells are treated as following: control, DOX, DOX + rhBMP (Bmpr1a agonist) and DOX + LDN193189 (Bmpr1a inhibitor). Cells with red fluorescence indicate favorable MMP while green fluorescence indicates damage.
Activité biologique
Protocole
Pureté et documentation
Références
Avis client
LDN193189 Tetrahydrochloride is a selective BMP type I receptor inhibitor, which efficiently inhibits ALK2 and ALK3 (IC50=5 nM and 30 nM, respectively), with weaker effects on ALK4, ALK5 and ALK7 (IC50≥500 nM). | ||
| ||
In Vitro | LDN193189 inhibits BMP4-mediated Smad1, Smad5 and Smad8 activation with great potency (IC50=5 nM) while retaining 200-fold selectivity for BMP signaling versus TGF-β signaling (IC50 for TGF-β ≥1,000 nM). MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. | |
---|---|---|
|
Mouse PASMCs grown are transiently transfected to 50% confluence in six-well plates with 0.3 μg Id1promoter luciferase reporter construct (BRE-Luc) in combination with 0.6 μg of plasmid expressing constitutively active forms of BMP type I receptors (caALK2, caALK3 or caALK6). For both reporter plasmids, 0.2 μg of pRL-TKRenilla luciferase are used to control for transfection efficiency. PASMCs are incubated with LDN193189 (2 nM-32 μM) or vehicle starting 1 h after transfection. Cell extracts are harvested and quantified relative promoter activity by the ratio of firefly to Renilla luciferase activity with the dual luciferase assay kit. MCE n'a pas confirmé de manière indépendante l'exactitude de ces méthodes. Ils sont pour référence seulement. |
Mice MCE n'a pas confirmé de manière indépendante l'exactitude de ces méthodes. Ils sont pour référence seulement. |
|
-
[1]. Yu PB, et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med, 2008, 14(12), 1363-1369.
[2]. Lee YC, et al. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res, 2011, 71(15), 5194-5203.
[3]. Yang L, et al. UK-92480 increases connexin 40 in smooth muscle cells through activation of BMP pathways in pulmonary arterial hypertension. Int J Clin Exp Pathol. 2014 Jul 15;7(8):4674-84.
* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
---|
DMSO / H2O | 1 mM | 1.8105 mL | 9.0526 mL | 18.1051 mL | 45.2628 mL |
5 mM | 0.3621 mL | 1.8105 mL | 3.6210 mL | 9.0526 mL | |
H2O | 10 mM | 0.1811 mL | 0.9053 mL | 1.8105 mL | 4.5263 mL |
15 mM | 0.1207 mL | 0.6035 mL | 1.2070 mL | 3.0175 mL | |
20 mM | 0.0905 mL | 0.4526 mL | 0.9053 mL | 2.2631 mL | |
25 mM | 0.0724 mL | 0.3621 mL | 0.7242 mL | 1.8105 mL | |
30 mM | 0.0604 mL | 0.3018 mL | 0.6035 mL | 1.5088 mL | |
40 mM | 0.0453 mL | 0.2263 mL | 0.4526 mL | 1.1316 mL | |
50 mM | 0.0362 mL | 0.1811 mL | 0.3621 mL | 0.9053 mL | |
60 mM | 0.0302 mL | 0.1509 mL | 0.3018 mL | 0.7544 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
- Stem Cell/Wnt TGF-beta/Smad
- Organoid TGF-β Receptor
-
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.
Keywords:
LDN193189 Tetrahydrochloride2310134-98-4DM-3189 TetrahydrochlorideOrganoidTGF-β ReceptorTransforming growth factor beta receptorsInhibitorinhibitorinhibit
Vos produits récemment consultés:
Demande en ligne
Your information is safe with us. * Required Fields.
Bulk Inquiry
Inquiry Information
- Nom du produit:
- LDN193189 Tetrahydrochloride
- Cat. No.:
- HY-12071A
- Quantité:
- MCE Japan Authorized Agent: